↓ Skip to main content

Hepatic safety profile and glycemic control of pioglitazone in more than 20,000 patients with type 2 diabetes mellitus: Postmarketing surveillance study in Japan

Overview of attention for article published in Diabetes Research & Clinical Practice, November 2006
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Hepatic safety profile and glycemic control of pioglitazone in more than 20,000 patients with type 2 diabetes mellitus: Postmarketing surveillance study in Japan
Published in
Diabetes Research & Clinical Practice, November 2006
DOI 10.1016/j.diabres.2006.08.017
Pubmed ID
Authors

Ryuzo Kawamori, Takashi Kadowaki, Morikazu Onji, Yutaka Seino, Yasuo Akanuma, on behalf of the PRACTICAL Study Group

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 3%
Brazil 1 3%
Unknown 30 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 16%
Student > Master 5 16%
Other 4 13%
Librarian 3 9%
Student > Doctoral Student 2 6%
Other 8 25%
Unknown 5 16%
Readers by discipline Count As %
Medicine and Dentistry 16 50%
Agricultural and Biological Sciences 5 16%
Biochemistry, Genetics and Molecular Biology 2 6%
Environmental Science 1 3%
Nursing and Health Professions 1 3%
Other 3 9%
Unknown 4 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 June 2020.
All research outputs
#20,726,842
of 25,460,914 outputs
Outputs from Diabetes Research & Clinical Practice
#2,598
of 3,195 outputs
Outputs of similar age
#81,644
of 86,534 outputs
Outputs of similar age from Diabetes Research & Clinical Practice
#22
of 24 outputs
Altmetric has tracked 25,460,914 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,195 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 86,534 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.